The Biden administration is moving forward with plans to reschedule marijuana from a Schedule I to a Schedule III drug, a significant shift in federal policy. This reclassification would acknowledge marijuana as less dangerous than drugs like heroin and fentanyl, potentially easing research barriers and modernizing outdated cannabis laws. However, experts caution that the rescheduling may not significantly benefit marijuana business owners, and research barriers may not entirely disappear. Notably, the DEA remains opposed to the reclassification, with DEA chief Anne Milgram indicating during a March 'Marijuana Meeting' that she would not sign off on the move. Despite this, the DOJ, HHS, and the White House have proceeded with the reclassification effort, marking a notable shift in federal drug policy.
“The DEA sent a memo to the DOJ seeking additional scientific input to determine whether marijuana has an accepted medical use, a key requirement for reclassification. But those concerns were overruled by DOJ attorneys.” https://t.co/21s33wLM7E https://t.co/nKAsLA80oP
It’s Official: Biden Administration Publishes Proposed Rule to Reschedule Cannabis https://t.co/NkCN65OL37
The story is here is that the DEA still opposes the relaxation of marijuana laws. DOJ (which outranks DEA), HHS, and the White House wanted to re-classify marijuana as less dangerous, so they did it without DEA. https://t.co/TmEutDa7cT
Biden Leans Into New Policy Reclassifying Marijuana, Marking Big Shift https://t.co/GLFb3C3BLx
Very interesting Dave Pozen post on what appears to be intra-executive branch disagreement about marijuana rescheduling. https://t.co/nXnq3n8IOp
Top U.S. drug agency a notable holdout in Biden’s push to loosen federal marijuana restrictions https://t.co/bTHI3Y7emO
Top U.S. drug agency a notable holdout in Biden's push to loosen federal marijuana restrictions | AP News $MSOS $MSOX $YOLO https://t.co/s9dQbMT9t4
AP Sources: In March, DEA chief Anne Milgram told her closest aides during what she called the “Marijuana Meeting” that she would not be signing off on the recent move by @TheJusticeDept to reclassify marijuana as a less dangerous drug. W/ @JimMustian https://t.co/SX1XMkVv4S
Top U.S. drug agency a notable holdout in Biden's push to loosen federal marijuana restrictions https://t.co/cFjWiUdYGZ
Marijuana research could still be difficult after rescheduling https://t.co/RIFiTvFWPu @mayagoldman_
Rescheduling Marijuana: How DOJ's Action Could Transform The Industry - Todd Harrison https://t.co/CsjP0oGmyq
Thank you @POTUS for taking this important step in the right direction. Our cannabis laws have been severely outdated in this country, but the reclassification of marijuana continues our fight to modernize the system. https://t.co/DDI1jbeb16
White Smoke: Habemus Proposed Rule Making on Marijuana Rescheduling! https://t.co/flU4MOEpW3 #Cannabis #Drugs #Federal @natsfert https://t.co/P7fw3pFWkk
Marijuana could get easier to study following the Biden administration's move to reclassify it as a less dangerous drug, but scientists say research barriers won't entirely disappear. https://t.co/VHzBjwvY5R
Biden 'Smokes' Trump On Marijuana Policy, Campaign Says After President's Rescheduling Announcement https://t.co/rSonTR89Aj
Marijuana is currently classified on the same level as heroin and as more dangerous than fentanyl. We are on the path to changing that. https://t.co/TE1iKFVF3T
Marijuana may soon be a Schedule III drug: What will change? https://t.co/oObtcqpH7k
Marijuana business owners hoping to benefit from the Biden administration’s move to reschedule the drug may be in for disappointment, according to experts. https://t.co/gFbdd0Efca